Revenue
0 USD
2020 Q1 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Fundies. English
Apotheca Biosciences, Inc.
EDGAR22 filing records in this dataset, filed from 2015-04-21 to 2019-06-20. Reported financial figures are available; chart coverage varies by period.
Latest quarter
Operating cash flow
-106 thousand USD
2020 Q1 · USD
Exact inputs and evidence
- Operating Cash Flow: -105673 USD Source
- Cash and cash equivalents
- 250 thousand USD Source
Exact value
250478 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 119 million shares Source
Exact value
118840795 shares
Reported share-count change
98.07% · 58.8 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
0 USD
2018-05-01 – 2019-04-30
Net income
-4.42 million USD
2018-05-01 – 2019-04-30
Exact inputs and evidence
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2019-06-20.
Financial data available through: 2019-01-31.
Coverage by financial measure
- Revenue: 1 of 11 periods available· newest 2019-01-31
- Operating income: 3 of 11 periods available· newest 2019-01-31
- Net income: 5 of 11 periods available· newest 2019-01-31
- Operating cash flow: 5 of 11 periods available· newest 2019-01-31
- Capital expenditure: 1 of 11 periods available· newest 2019-01-31
- Total assets: 1 of 11 periods available· newest 2019-01-31
- Total liabilities: 1 of 11 periods available· newest 2019-01-31
- Current assets: 1 of 11 periods available· newest 2019-01-31
- Current liabilities: 1 of 11 periods available· newest 2019-01-31
- Cash and cash equivalents: 1 of 11 periods available· newest 2019-01-31
- long term debt: No compatible figures in this window
- Shares outstanding: 1 of 11 periods available· newest 2019-01-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
No unambiguous prior-year comparison is available for the latest reporting period.
Comparable inputs unavailable for: Revenue, Net income, Operating cash flow, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2019 2018-02-26 – 2019-01-31
- Revenue USD 0
- Operating costs Derived USD 2.28 million
- Operating income −USD 2.28 million
- Tax, interest and other Derived USD 236,042
- Net income −USD 2.51 million
Cash
- Operating cash flow −USD 428,235
- Capital expenditure USD 6,623
- Free cash flow Derived −USD 434,858
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2019 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2019 2018-02-26 – 2019-01-31 | 0 | 2276398 Derived | -2276398 | 236042 Derived | -2512440 | -434858 Derived | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 0 2019
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Revenue | 0 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Year over year | No prior comparable period |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Operating margin | Not reported |
|
| 2019 | Net margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -428.2K 2019
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Operating cash flow | -428235 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD -434.9K 2019
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Free cash flow | -434858 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
808% 2019
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Liabilities / assets | 808% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
0.12× 2019
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Current assets / current liabilities | 0.12× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2015 2014-02-01 – 2015-01-31 | −USD 21,575 Exact valueExact value: -21575 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 29,075 Exact valueExact value: -29075 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2016 2015-02-01 – 2016-01-31 | −USD 39,388 Exact valueExact value: -39388 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 25,529 Exact valueExact value: -25529 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2016-02-01 – 2017-01-31 | −USD 17,786 Exact valueExact value: -17786 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3,341 Exact valueExact value: -3341 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2017-02-01 – 2018-01-31 | −USD 195,780 Exact valueExact value: -195780 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 34,089 Exact valueExact value: -34089 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2018-02-26 – 2019-01-31 | −USD 2.51 million Exact valueExact value: -2512440 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 428,235 Exact valueExact value: -428235 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 6,623 Exact valueExact value: 6623 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 434,858 Calculation and evidence-428235 − 6623 USD Exact free cash flow: -434858 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
22 filings · 596 latest values · 596 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001632053, 1632053, edgar:1632053
Also known as APOTHECA BIOSCIENCES, INC.,, Apotheca Biosciences, Inc., Cannabis Leaf, Inc., Cannabis Leaf, Inc. , Pacificorp Holdings Ltd.